cuts
Evonik swings axe at API plant
December 18, 2012Manufacturing and Production API, Evonik, cuts, lilly
Fine chemicals company Evonik Degussa has announced job cuts as part of an efficiency drive at a US plant making …
Reprieve for GSK’s Sligo plant
October 16, 2012Manufacturing and Production GSK, Ireland, Sligo, cuts
GlaxoSmithKline has reversed its earlier plan to close a manufacturing plant in Sligo, Ireland, and says it now intends to …
Novartis pledges to maintain R&D presence in Horsham
August 14, 2012Manufacturing and Production, Research and Development Horsham, NIBR, Novartis, R&D, cuts
Novartis has confirmed that it intends to maintain a presence at its site in Horsham, UK, which has already seen …
Amgen unveils plan to close Epogen plant
August 14, 2012Manufacturing and Production Amgen, Epogen, cuts, omontys
Amgen has said it will close down a manufacturing facility in Longmont, Colorado, in the face of declining sales of …
Merck Serono says dispute over Geneva closure is resolved
August 10, 2012Manufacturing and Production Geneva, Merck Serono, Quintiles, cuts
Merck Serono says it has reached agreement with groups representing workers affected by the closure and downsizing of sites in …
Pfizer Sandwich site sold to private consortium
August 3, 2012Business Services, Research and Development, Sales and Marketing Jobs, Pfizer, R&D, Sandwich, cuts
The Sandwich Discovery Park in Kent has found new owners, 18 months after Pfizer decided to pull out from the …
Jobs under threat in Actelion cost saving
July 12, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Actelion, R&D, Tracleer, cuts
Swiss speciality pharmaceutical company Actelion has unveiled a new cost saving plan which could include the loss of 260 jobs …
Savient appoints new president and chief executive
July 10, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Ferrari, Savient, cuts
Savient Pharmaceuticals has appointed Louis Ferrari to the role of president and chief executive for the firm. Ferrari succeeds Savient’s …
More job cuts planned at Sanofi, says union
July 6, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, Viehbacher, cuts
Sanofi has confirmed that it is considering a restructuring of its operations in France, but has refused to comment on …
Quintiles offers lifeline to Merck Serono employees
June 28, 2012Manufacturing and Production Geneva, Merck Serono, Quintiles, cuts, manufacturing
Quintiles has said it will make at least 100 job offers within the next three months to workers set to …
Roche cuts 1,000 R&D jobs
June 27, 2012Research and Development, Sales and Marketing AZ, Genentech, Novartis, R&D, Roche, cuts
Roche will make major cuts to its research operations in the US and revamp operations in Europe. Roche will close …
Merck Serono tweaks Swiss restructuring plans
June 20, 2012Manufacturing and Production, Sales and Marketing Merck Serono, cuts, restructuring
Merck KGaA has finalised the restructuring plans at Swiss drugs unit Merck Serono, confirming that it intends to close its …
Lundbeck to slash 600 jobs in Europe
June 15, 2012Sales and Marketing Cipralex, Europe, Lundbeck, austerity, cuts
Lundbeck will cut 600 jobs from its operations in Europe as its Cipralex parent expiry continues to erode revenue. The …
AstraZeneca swings axe at Swedish plant
June 14, 2012Sales and Marketing AstraZeneca, Brennan, Sweden, Södertälje, cuts
AstraZeneca will be cutting 400 jobs from its facility in Sweden, the company has confirmed. Speaking to the TT news …
Lipitor fallout prompts Pfizer to cut Irish workforce
June 7, 2012Manufacturing and Production Amgen, Ireland, Lipitor, Pfizer, cuts, patent loss
Falling demand for blockbuster cholesterol drug Lipitor has prompted Pfizer to cut staff levels at two manufacturing facilities in Ireland. …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
